Factors associated with adherence to pharmaceutical treatment for rheumatoid arthritis patients: A systematic review

Seminars in Arthritis and Rheumatism

Volumn 43, Issue 1, 2013, Pages 18-28

  Pasma, Annelieke ^a   van't Spijker, Adriaan ^a   Hazes, Johanna M W ^a   Busschbach, Jan J V ^a   Luime, Jolanda J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Adherence; Medication; Rheumatoid arthritis

Indexed keywords

ACETYLSALICYLIC ACID; ANTIRHEUMATIC AGENT; BIOLOGICAL PRODUCT; DISEASE MODIFYING ANTIRHEUMATIC DRUG; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; SLOW ACTING ANTIRHEUMATIC DRUG; TUMOR NECROSIS FACTOR ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; COGNITION; CORRELATION ANALYSIS; DEMOGRAPHY; DRUG COST; HEALTH BELIEF MODEL; HEALTH CARE PERSONNEL; HEALTH INSURANCE; HUMAN; LIFESTYLE; MEDICAL INFORMATION; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY CONTROL; RACE DIFFERENCE; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; SOCIAL PSYCHOLOGY; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT;

ADHERENCE; MEDICATION; RHEUMATOID ARTHRITIS;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; HUMANS; MEDICATION ADHERENCE;

EID: 84881555676     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2012.12.001     Document Type: Article

References (36)

1. Kwoh C.K., Anderson L.G., Greene J.M., Johnson D.A., O'Dell J.R., Robbins M.L., et al. Guidelines for the management of rheumatoid arthritis: 2002 update-American College of Rheumatology subcommittee on rheumatoid arthritis guidelines. Arthritis Rheum 2002, 46(2):328-346.
2. Smolen J., Aletaha D., Bijlsma J.W.J., Breedveld F.C., Boumpas D., Burmester G., et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 2010, 69(4):631-637.
3. Harrold L.R., Andrade S.E. Medication adherence of patients with selected rheumatic conditions: a systematic review of the literature. Semin Arthritis Rheum 2009, 38(5):396-402.
4. Haynes R. Determinants of compliance: the disease and the mechanics of treatment 1979, Johns Hopkins University Press, Baltimore, MD.
5. Koncz T., Pentek M., Brodszky V., Ersek K., Orlewska E., Gulacsi L. Adherence to biologic DMARD therapies in rheumatoid arthritis. Expert Opin Biol Ther 2010, 10(9):1367-1378.
6. Salt E., Frazier S.K. Adherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a narrative review of the literature. Orthop Nurs 2010, 29(4):260-275.
7. Park D.C., Hertzog C., Leventhal H., Morrell R.W., Leventhal E., Birchmore D., et al. Medication adherence in rheumatoid arthritis patients: older is wiser. J Am Geriatr Soc 1999, 47(2):172-183.
8. World Health Organization. Adherence to long-term therapies: evidence for action. Geneva, Switzerland; 2003.
9. Achaval S.D., Suarez-Almazor M.E. Treatment adherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and systemic lupus erythematosus. Int J Clin Rheumatol 2010, 5(3):313-326.
10. Deyo R.A. Compliance with therapeutic regimens in arthritis: issues, current status, and a future agenda. Semin Arthritis Rheum 1982, 12(2):233-244.
11. Rosenstock I.M., Strecher V.J., Becker M.H. Social learning theory and the Health Belief Model. Health Educ Quart 1988, 15(2):175-183.
12. Sanderson S., Tatt I.D., Higgins J.P.T. Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliograph. Int J Epidemiol 2007, 36(3):666-676.
13. van Tulder M., Furlan A., Bombardier C., Bouter L. Updated method guidelines for systematic reviews in the Cochrane Collaboration Back Review Group. Spine 2003, 28(12):1290-1299.
14. Van Den Bemt B.J., Van Den Hoogen F.H., Benraad B., Hekster Y.A., Van Riel P.L., Van Lankveld W. Adherence rates and associations with nonadherence in patients with rheumatoid arthritis using disease modifying antirheumatic drugs. J Rheumatol 2009, 36(10):2164-2170.
15. Treharne G.J., Lyons A.C., Kitas G.D. Medication adherence in rheumatoid arthritis: effects of psychosocial factors. Psychol Health Med 2004, 9(3):337-349.
16. Viller F., Guillemin F., Briancon S., Moum T., Suurmeijer T., Van Den Heuvel W. Compliance to drug treatment of patients with rheumatoid arthritis: a 3 year longitudinal study. J Rheumatol 1999, 26(10):2114-2122.
17. Owen S.G., Friesen W.T., Roberts M.S., Flux W. Determinants of compliance in rheumatoid arthritic patients assessed in their home environment. Br J Rheumatol 1985, 24(4):313-320.
18. Lee P., Tan L.J. Drug compliance in outpatients with rheumatoid arthritis. Aust N Z J Med 1979, 9(3):274-277.
19. Lorish C.D., Richards B., Brown S. Missed medication doses in rheumatic arthritis patients: intentional and unintentional reasons. Arthritis Care Res 1989, 2(1):3-9.
20. Beck N.C., Parker J.C., Frank R.G., Geden E.A., Kay D.R., Gamache M., et al. Patients with rheumatoid arthritis at high risk for noncompliance with salicylate treatment regimens. J Rheumatol 1988, 15(7):1081-1084.
21. Curkendall S., Patel V., Gleeson M., Campbell R.S., Zagari M., Dubois R. Compliance with biologic therapies for rheumatoid arthritis: do patient out-of-pocket payments matter?. Arthritis Rheum 2008, 59(10):1519-1526.
22. de Thurah A., Norgaard M., Johansen M.B., Stengaard-Pedersen K. Methotrexate compliance among patients with rheumatoid arthritis: the influence of disease activity, disease duration, and co-morbidity in a 10-year longitudinal study. Scand J Rheumatol 2010, 39(3):197-205.
23. Li P., Blum M.A., Von Feldt J., Hennessy S., Doshi J.A. Adherence, discontinuation, and switching of biologic therapies in medicaid enrollees with rheumatoid arthritis. Value Health 2010, 13(6):805-812.
24. Borah B.J., Huang X., Zarotsky V., Globe D. Trends in RA patients' adherence to subcutaneous anti-TNF therapies and costs. Curr Med Res Opin 2009, 25(6):1365-1377.
25. de Thurah A., Norgaard M., Harder I., Stengaard-Pedersen K. Compliance with methotrexate treatment in patients with rheumatoid arthritis: influence of patients' beliefs about the medicine. A prospective cohort study. Rheumatol Int 2009, 1-8.
26. Neame R., Hammond A. Beliefs about medications: a questionnaire survey of people with rheumatoid arthritis. Rheumatology 2005, 44(6):762-767.
27. Geertsen H.R., Gray R.M., Ward J.R. Patient non-compliance within the context of seeking medical care for arthritis. J Chronic Dis 1973, 26(11):689-698.
28. Ferguson K., Bole G.G. Family support, health beliefs, and therapeutic compliance in patients with rheumatoid arthritis. Patient Couns Health Educ 1979, 1(3):101-105.
29. Tuncay R., Eksioglu E., Cakir B., Gurcay E., Cakci A. Factors affecting drug treatment compliance in patients with rheumatoid arthritis. Rheumatol Int 2007, 27(8):743-746.
30. Contreras-Yanez I., Ponce De Leon S., Cabiedes J., Rull-Gabayet M., Pascual-Ramos V. Inadequate therapy behavior is associated to disease flares in patients with rheumatoid arthritis who have achieved remission with disease-modifying antirheumatic drugs. Am J Med Sci 2010, 340(4):282-290.
31. diMatteo M.R. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care 2004, 42(3):200-209.
32. Jackson C.A., Clatworthy J., Robinson A., Horne R. Factors associated with non-adherence to oral medication for inflammatory bowel disease: a systematic review. Am J Gastroenterol 2010, 105(3):525-539.
33. Ingersoll K.S., Cohen J. The impact of medication regimen factors on adherence to chronic treatment: a review of literature. J Behav Med 2008, 31(3):213-224.
34. Brawley L.R., Culos-Reed S.N. Studying adherence to therapeutic regimens: overview, theories, recommendations. Control Clin Trials 2000, 21(5 Suppl):156S-163SS.
35. Krueger K.P., Berger B.A., Felkey B. Medication adherence and persistence: a comprehensive review. Adv Ther 2005, 22(4):314-356.
36. Jin J., Sklar G.J., Oh V.M.S., Li S.C. Factors affecting therapeutic compliance: a review from the patient's perspective. Ther Clin Risk Manag 2008, 4(1):269-286.